BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9879423)

  • 1. Fluorine-18 fluorodeoxyglucose positron emission tomography imaging of parotid mass lesions.
    Okamura T; Kawabe J; Koyama K; Ochi H; Yamada R; Sakamoto H; Matsuda M; Ohashi Y; Nakai Y
    Acta Otolaryngol Suppl; 1998; 538():209-13. PubMed ID: 9879423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective review: usefulness of a number of imaging modalities including CT, MRI, technetium-99m pertechnetate scintigraphy, gallium-67 scintigraphy and F-18-FDG PET in the differentiation of benign from malignant parotid masses.
    Ozawa N; Okamura T; Koyama K; Nakayama K; Kawabe J; Shiomi S; Yamane H; Inoue Y
    Radiat Med; 2006 Jan; 24(1):41-9. PubMed ID: 16715661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of FDG PET and salivary gland scintigraphy for parotid tumors.
    Uchida Y; Minoshima S; Kawata T; Motoori K; Nakano K; Kazama T; Uno T; Okamoto Y; Ito H
    Clin Nucl Med; 2005 Mar; 30(3):170-6. PubMed ID: 15722820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four cases of Warthin's tumor of the parotid gland detected with FDG PET.
    Horiuchi M; Yasuda S; Shohtsu A; Ide M
    Ann Nucl Med; 1998 Feb; 12(1):47-50. PubMed ID: 9559962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomographic imaging of pleomorphic adenoma in the parotid gland.
    Matsuda M; Sakamoto H; Okamura T; Nakai Y; Ohashi Y; Kawabe J; Ochi H; Wakasa K
    Acta Otolaryngol Suppl; 1998; 538():214-20. PubMed ID: 9879424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is There a Role for PET/CT Parameters to Characterize Benign, Malignant, and Metastatic Parotid Tumors?
    Kendi AT; Magliocca KR; Corey A; Galt JR; Switchenko J; Wadsworth JT; El-Deiry MW; Schuster DM; Saba NF; Hudgins PA
    AJR Am J Roentgenol; 2016 Sep; 207(3):635-40. PubMed ID: 27276388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parotid gland tumors: preliminary data for the value of FDG PET/CT diagnostic parameters.
    Hadiprodjo D; Ryan T; Truong MT; Mercier G; Subramaniam RM
    AJR Am J Roentgenol; 2012 Feb; 198(2):W185-90. PubMed ID: 22268210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of metabolic heterogeneity as a reliable parameter for differentiating malignant parotid gland tumors.
    Kim BS; Kim SJ; Pak K
    Ann Nucl Med; 2016 Jun; 30(5):346-54. PubMed ID: 26897010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does 18F-FDG PET/CT play a role in the differential diagnosis of parotid masses.
    Rubello D; Nanni C; Castellucci P; Rampin L; Farsad M; Franchi R; Mariani G; Menaldo G; Fanti S
    Panminerva Med; 2005 Sep; 47(3):187-9. PubMed ID: 16462726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbon-11 choline positron emission tomography in musculoskeletal tumors: comparison with fluorine-18 fluorodeoxyglucose positron emission tomography.
    Yanagawa T; Watanabe H; Inoue T; Ahmed AR; Tomiyoshi K; Shinozaki T; Oriuchi N; Endo K; Takagishi K
    J Comput Assist Tomogr; 2003; 27(2):175-82. PubMed ID: 12703009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of parotid gland incidentalomas on (18)F-FDG PET/CT.
    Makis W; Ciarallo A; Gotra A
    Clin Imaging; 2015; 39(4):667-71. PubMed ID: 25888252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of conventional whole-body ¹⁸F-FDG PET/CT in the incidental findings of parotid masses.
    Wang HC; Zuo CT; Hua FC; Huang ZM; Tan HB; Zhao J; Guan YH
    Ann Nucl Med; 2010 Oct; 24(8):571-7. PubMed ID: 20640540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography in Warthin's tumor mimicking malignancy impacts the evaluation of head and neck patients.
    Rassekh CH; Cost JL; Hogg JP; Hurst MK; Marano GD; Ducatman BS
    Am J Otolaryngol; 2015; 36(2):259-63. PubMed ID: 25523505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-[Fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography versus whole-body diffusion-weighted MRI for detection of malignant lesions: initial experience.
    Komori T; Narabayashi I; Matsumura K; Matsuki M; Akagi H; Ogura Y; Aga F; Adachi I
    Ann Nucl Med; 2007 Jun; 21(4):209-15. PubMed ID: 17581719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of incidental fluorodeoxyglucose uptake in the parotid glands and its impact on patient management.
    Basu S; Houseni M; Alavi A
    Nucl Med Commun; 2008 Apr; 29(4):367-73. PubMed ID: 18317302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorine-18-fluorodeoxyglucose PET versus thallium-201 scintigraphy evaluation of thyroid tumors.
    Uematsu H; Sadato N; Ohtsubo T; Tsuchida T; Nakamura S; Sugimoto K; Waki A; Takahashi N; Yonekura Y; Tsuda G; Saito H; Hayashi N; Yamamoto K; Ishii Y
    J Nucl Med; 1998 Mar; 39(3):453-9. PubMed ID: 9529291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective diagnostic accuracy study of F-18 fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of indeterminate renal masses.
    Ozülker T; Ozülker F; Ozbek E; Ozpaçaci T
    Nucl Med Commun; 2011 Apr; 32(4):265-72. PubMed ID: 21301376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET imaging of musculoskeletal tumours with fluorine-18 alpha-methyltyrosine: comparison with fluorine-18 fluorodeoxyglucose PET.
    Watanabe H; Inoue T; Shinozaki T; Yanagawa T; Ahmed AR; Tomiyoshi K; Oriuchi N; Tokunaga M; Aoki J; Endo K; Takagishi K
    Eur J Nucl Med; 2000 Oct; 27(10):1509-17. PubMed ID: 11083540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of hemangioma by positron emission tomography: role in a multimodality approach.
    Hatayama K; Watanabe H; Ahmed AR; Yanagawa T; Shinozaki T; Oriuchi N; Aoki J; Takeuchi K; Endo K; Takagishi K
    J Comput Assist Tomogr; 2003; 27(1):70-7. PubMed ID: 12544246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.